← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2013Last known activity
Mar 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT06846138Lead sponsorN/AMar 1, 2025
- NCT06846138Sponsor investigatorN/AMar 1, 2025
- NCT06681415Lead sponsorPhase 4Sep 1, 2022
- NCT06142136Lead sponsorN/AMar 28, 2021
- NCT06142136Overall official - principal investigatorN/AMar 28, 2021
- NCT05502068Lead sponsorN/AFeb 1, 2021
- NCT05502068Overall official - principal investigatorN/AFeb 1, 2021
- NCT02744976Reponsible party - principal investigatorPhase 4Feb 1, 2016
- NCT02744976Lead sponsorPhase 4Feb 1, 2016
- NCT01951235Overall official - principal investigatorPhase 2Jan 1, 2013
Details
- Last known activity
- Mar 1, 2025